Records 1 - 2
| The deletion variant of a2b-adrenergic receptor is associated with decreased risk in Alzheimer's disease and mild cognitive impairment.
Journal of the neurological sciences 2013 Mar .
Koutroumani M, Daniilidou M, Giannakouros T, Proitsi P, Liapi D, Germanou A, Nikolakaki E, Tsolaki M
| Human response to alpha2-adrenergic agonist stimulation studied in an isolated vascular bed in vivo: Biphasic influence of dose, age, gender, and receptor genotype.
Clinical pharmacology and therapeutics 2005 May 77 (5): 388-403.
King Danuta, Etzel Jason P, Chopra Shagun, Smith Joshua, Cadman Peter E, Rao Fangwen, Funk Stephen D, Rana Brinda K, Schork Nicholas J, Insel Paul A, O'Connor Daniel